Clinical trials
ANXIETY DISORDERS (or Anxiety and Phobic Neuroses) clinical trials
Below are recruiting anxiety disorders (or anxiety and phobic neuroses) clinical trials, each written for real people, not researchers. We’re tracking 911 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07489651RecruitingPhase 2
New treatment for generalized anxiety disorder
This trial tests a new medication called RE104 for people with generalized anxiety disorder (GAD). The goal is to see if it helps reduce anxiety symptoms safely.
Birmingham, AlabamaAges 18–74 - NCT07478744RecruitingPhase 2
Study for generalized anxiety disorder with SYT-510
This trial tests a new medicine called SYT-510 for adults with generalized anxiety disorder who are not currently taking medication. It aims to see if the drug reduces anxiety and is safe.
LondonAges 18–55 - NCT07477990RecruitingPhase 3
Testing a digital device for anxiety treatment
This trial is testing a digital device called Aurora that helps treat moderate to severe anxiety. It compares the device to standard anxiety medications, so you may receive either the device or a pill. The goal is to see if the device can work as well as medication without the side effects.
Mexico City, Mexico CityAges 18–65 - NCT07466277Recruiting
Brain stimulation for social anxiety disorder
This study tests if a non-invasive brain stimulation technique called theta burst stimulation can help treat social anxiety disorder. It uses magnetic pulses to target a brain area involved in fear and anxiety, and you may benefit if you have social anxiety and are not taking certain medications.
Hangzhou, ZhejiangAges 16–70 - NCT07429578Recruiting
Brain stimulation for anxiety and insomnia
This study tests whether a gentle, non-invasive brain stimulation technique (tACS) can help people who have both generalized anxiety and long-term sleep problems. It aims to see if this treatment can reduce anxiety and improve sleep.
São Paulo, São PauloAges 18–65 - NCT07405463Enrolling by invitation
Can brain stimulation help reduce fear in anxiety disorders?
This study tests whether a non-invasive brain stimulation technique called tDCS can help people with anxiety disorders overcome conditioned fear responses. It aims to improve how the brain relearns safety signals.
Guangzhou, GuangdongAges 18–65 - NCT07330648RecruitingPhase 2
Crisugabalin for generalized anxiety disorder
This study tests a new investigational drug called crisugabalin for people with generalized anxiety disorder (GAD) who have not found enough relief from at least two other anxiety medications. The trial aims to see if crisugabalin can safely reduce anxiety symptoms.
Hefei, AnhuiAges 18 years+ - NCT07325929Recruiting
Online radical acceptance for social anxiety
This study tests if an online program that teaches radical acceptance skills can help people with social anxiety. You will learn to accept anxious feelings instead of fighting them, which may reduce your social fears.
HaifaAges 18–45 - NCT07323784RecruitingPhase 2
Study of NTX-1472 for social anxiety disorder
This trial tests an investigational medicine called NTX-1472 to see if it helps people with social anxiety disorder. Participation involves taking the study drug and attending scheduled visits.
Encino, CaliforniaAges 18–65 - NCT07272213Recruiting
Thyroid hormone levels, mood, and sexual health in pregnancy
This study looks at how thyroid-stimulating hormone (TSH) levels during pregnancy are linked to depression, anxiety, and sexual function in pregnant women.
Istanbul, GaziosmanpaşaAges 18–45 - NCT06844058Recruiting
Religious vs. standard hypnosis for anxiety and depression
This study compares two types of hypnosis (one that includes Islamic themes and one that follows a standard approach) to see which works better for anxiety and depression. It is designed for Muslim adults who are feeling stressed but do not have a formal mental health diagnosis.
IstanbulAges 18–65 - NCT06901128Recruiting
Video vs. in-person talk therapy for teens with social anxiety
This study compares talking therapy (cognitive therapy) for social anxiety given through video calls versus in-person office visits. It aims to help teens feel less anxious and more confident in social situations.
Ottestad, InnlandetAges 14–18 - NCT07255131Recruiting
Online talk therapy for cystic fibrosis
This study tests an online cognitive behavioral therapy (a type of talk therapy) program designed for people with cystic fibrosis. It aims to help improve mental health and coping skills through 13 video sessions.
AthensAges 18–70 - NCT05863520Recruiting
Two school programs to help anxious autistic students
This study compares two school-based programs to reduce anxiety in autistic students ages 8–14. You may be able to help test which approach works better when delivered by trained school staff with caregiver involvement.
Aurora, ColoradoAges 7–15 - NCT06278909Recruiting
Nerve stimulation for stubborn anxiety
This study tests a new, non-invasive treatment using mild electrical stimulation on a nerve in your face (trigeminal nerve) to help with anxiety that hasn't improved with other treatments. It aims to see if this approach is safe and helpful for people with generalized anxiety disorder who have not responded to standard medications.
Kingston, OntarioAges 18–65 - NCT07201844Recruiting
Does patient choice improve online anxiety treatment?
This trial tests whether letting patients choose their own treatment approach within an online therapy program helps them more for generalized anxiety disorder. You'd receive 10 weeks of internet-delivered cognitive behavior therapy (iCBT) from home.
Stockholm, SverigeAges 18 years+ - NCT07192367RecruitingPhase 4
Virtual reality vs. medication for social anxiety in teens
This trial tests whether virtual reality therapy works as well as a common medication (sertraline) for teenagers with social anxiety disorder. Participants will be assigned to either VR exposure therapy or medication, and the study aims to find out which approach is more effective.
KocaeliAges 12–17 - NCT07174947RecruitingPhase 2
Fluoxetine plus immunotherapy for advanced liver cancer with depression
This study tests whether adding the antidepressant fluoxetine (Prozac) to standard immunotherapy can help treat advanced liver or bile duct cancer in people who also have depression or anxiety. You must not have received any prior cancer treatment and be ready to start immunotherapy as your first therapy.
Wenzhou, ZhejiangAges 18–80 - NCT07121712Recruiting
Brain Stimulation for Generalized Anxiety Disorder
This study tests a non-invasive brain stimulation technique (cTBS) to treat Generalized Anxiety Disorder. You will receive navigated stimulation sessions, and no surgery or medication is used.
Hefei, AnhuiAges 18–60 - NCT07119515Recruiting
Comparing online vs. in-person therapy for anxiety
This study compares two ways of receiving cognitive behavioral therapy (CBT) for generalized anxiety disorder: over video calls (teletherapy) or in person. It aims to see if online therapy works just as well as face-to-face sessions.
Faisalabad, Punjab ProvinceAges 18–45 - NCT06218030RecruitingPhase 4
L-methylfolate for treatment-resistant anxiety
This study tests whether adding L-methylfolate (a form of vitamin B9) to your current antidepressant can help with generalized anxiety disorder that has not responded to other treatments. It is for adults who are already on a stable dose of an SSRI or SNRI medication.
Kingston, OntarioAges 18–65 - NCT07017322Recruiting
Brain stimulation for mealtime anxiety in eating disorders
This study tests a gentle, noninvasive brain stimulation device (like a mild electrical current) to see if it can reduce mealtime anxiety for adults with eating disorders in an inpatient program. If it works, it might help you feel calmer and eat more comfortably.
Oconomowoc, WisconsinAges 18–30 - NCT06969170RecruitingPhase 2
Psilocybin oral solution for generalized anxiety disorder trial
This study tests a psilocybin oral solution in adults with generalized anxiety disorder (GAD). It aims to see if the drug is safe, tolerable, and helpful for reducing anxiety symptoms.
Kingston, OntarioAges 18–60 - NCT06928428Enrolling by invitation
Online talk therapy for depression or anxiety
This study tests if a type of talk therapy called metacognitive therapy, delivered partly online, helps adults with depression or generalized anxiety. It aims to see if this blended approach works well in primary care.
Stockholm, Stockholm CountyAges 18 years+
Hear when a new ANXIETY DISORDERS (or Anxiety and Phobic Neuroses) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for anxiety disorders (or anxiety and phobic neuroses)?
- Yes. Clin2 currently lists 911 recruiting anxiety disorders (or anxiety and phobic neuroses) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a anxiety disorders (or anxiety and phobic neuroses) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a anxiety disorders (or anxiety and phobic neuroses) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.